The Southeast Medical Device Association annual conference is right around the corner, May 2 – 4, 2018, this year in Greenville, South Carolina. GCMI closely shares and supports SEMDA’s mission of helping advance medtech innovation in the Southeast. GCMI CEO Tiffany Wilson (chair), Director of Training and Education Kelley Bennett and Project Engineer Dersi Patel serve on the Medtech Women at SEMDA board. Our Executive Director of Business Strategy Andrew Stevenson currently serves on the SEMDA board as well. It really does take a village to advance medtech innovation from concept to commercialization.
The reasons are many, but here is a quick snapshot of why we are counting down the days until SEMDA 2018.
The Opening Keynote
Joe S. Lee, Executive Director, Life Sciences for JPMorgan is giving the opening keynote. Joe leads the Middle Market Banking coverage of life science companies in the Southeast; originating credit, treasury services, capital markets, and investment banking opportunities. Given the need for new investment in the many promising young medtech and bio-science innovators and companies in the southeast, we are eager to hear him talk about the value in our medtech ecosystem, what makes a highly investable early growth stage medtech company and more.
Medtech Marketing and the Regulatory Minefield
GCMI’s Design and Development Director Mike Fisher will serve on a panel led by Paul Snyder, VP of Healthcare for Write2Market, and provide his insights on the impact of regulatory pathway decisions for marketing teams and budget requirements for medtech innovators. The discussion titled “Medtech Marketing and the Regulatory Minefield” will take place Friday, May 4 from 11:15 a.m. – 12:15 pm during SEMDA 2018 concurrent session #5.
Mike and Paul will be joined by Allyson Bower-Willner a member of the Medtech Women at SEMDA board of directors. Together they will discuss how to avoid the many ways of going off-label or contra-indication that can spell disaster for companies of any size. How do medtech marketers ensure this does not happen to them while accomplishing their sales supporting mission effectively? Add it to your calendar!
Speaking of regulatory issues, here are six things innovators need to know about the FDA approval process at “Phase Zero.”
Networking with medtech startups innovating the Southeast
We are excited to meet the SEMDA 2018 PitchRounds presenting companies and the other medical device startups that attend the flagship conference- knowing we can help them efficiently achieve their next goal or inflection point be it regulatory submission, approval, preclinical services or bioskills training.
“From concept to development through clinical trials, the infrastructure needed to support successful medtech innovation resides either in our facilities or very close to them,” says Tiffany Wilson, CEO of GCMI. “GCMI’s new accelerator fills a gap in the ecosystem which now enables us to locally support high potential young medtech companies in Atlanta and the southeast.”
Connect with GCMI During #SEMDA2018
For medtech innovators seeking to bring novel technologies and therapies to life- concept to cure, through design and development, preclinical testing and FDA approval all the way to commercialization- let’s connect! Contact Deepal Panchal or Andrew Stevenson to set up a meeting during SEMDA 2018! You can find the full conference agenda here.
See you in Greenville, SC next month!
You can also follow both GCMI on LinkedIn and Twitter.